Candriam S.C.A. - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 43 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$395,000
+39.1%
380,0000.0%0.01%
+25.0%
Q4 2018$284,000
-64.8%
380,0000.0%0.00%
-63.6%
Q3 2018$806,000
-8.2%
380,0000.0%0.01%
-21.4%
Q2 2018$878,000
-13.8%
380,000
+18.8%
0.01%
-17.6%
Q1 2018$1,018,000
-22.4%
320,0000.0%0.02%
-26.1%
Q4 2017$1,312,000
-21.5%
320,000
-13.5%
0.02%
-20.7%
Q3 2017$1,672,000
+134.5%
370,000
+72.9%
0.03%
+123.1%
Q2 2017$713,000
-63.8%
214,0000.0%0.01%
-65.8%
Q1 2017$1,971,000
+23.5%
214,000
+3.4%
0.04%
+2.7%
Q4 2016$1,596,000
-16.4%
207,000
+24.0%
0.04%
-19.6%
Q3 2016$1,909,000
-7.1%
167,0000.0%0.05%
-13.2%
Q2 2016$2,056,000
+94.7%
167,000
+59.0%
0.05%
+103.8%
Q1 2016$1,056,000
-62.7%
105,000
-16.5%
0.03%
-65.8%
Q4 2015$2,833,000
+88.2%
125,700
+38.6%
0.08%
+105.4%
Q3 2015$1,505,000
-16.4%
90,700
+13.4%
0.04%0.0%
Q2 2015$1,800,000
-41.8%
80,000
-33.3%
0.04%
-40.3%
Q1 2015$3,094,000
+58.0%
120,000
+33.3%
0.06%
+51.2%
Q4 2014$1,958,00090,0000.04%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
BVF INC/IL 4,042,989$8,571,0000.75%
NEXTHERA CAPITAL LP 634,715$1,346,0000.26%
Endurant Capital Management LP 219,114$465,0000.21%
Birchview Capital, LP 118,689$252,0000.16%
Perceptive Advisors 2,620,897$5,556,0000.15%
Alambic Investment Management, L.P. 53,972$114,0000.09%
Sofinnova Investments, Inc. 395,744$839,0000.08%
Kazazian Asset Management, LLC 31,475$67,0000.06%
Broadfin Capital, LLC 200,000$424,0000.06%
ESSEX INVESTMENT MANAGEMENT CO LLC 96,639$205,0000.02%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders